DK3006462T3 - Alfa-1-antitrypsin-sammensætning - Google Patents
Alfa-1-antitrypsin-sammensætning Download PDFInfo
- Publication number
- DK3006462T3 DK3006462T3 DK15193455.1T DK15193455T DK3006462T3 DK 3006462 T3 DK3006462 T3 DK 3006462T3 DK 15193455 T DK15193455 T DK 15193455T DK 3006462 T3 DK3006462 T3 DK 3006462T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- antitrypsin
- composition
- antitrypsin composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
- B01D15/327—Reversed phase with hydrophobic interaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/461—Flow patterns using more than one column with serial coupling of separation columns
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/334,303 US7777006B2 (en) | 2002-12-31 | 2002-12-31 | Method for purification of alpha-1-antitrypsin |
EP10182334.2A EP2295126B1 (en) | 2002-12-31 | 2003-12-19 | Alpha-1-antitrypsin composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3006462T3 true DK3006462T3 (da) | 2019-06-17 |
Family
ID=32655016
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15193455.1T DK3006462T3 (da) | 2002-12-31 | 2003-12-19 | Alfa-1-antitrypsin-sammensætning |
DK10182334.2T DK2295126T3 (da) | 2002-12-31 | 2003-12-19 | Alpha-1-antitrypson-sammensætning |
DK03814875.5T DK1590061T3 (da) | 2002-12-31 | 2003-12-19 | Fremgangsmåde til rensning af alfa-1-antitrypsin |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10182334.2T DK2295126T3 (da) | 2002-12-31 | 2003-12-19 | Alpha-1-antitrypson-sammensætning |
DK03814875.5T DK1590061T3 (da) | 2002-12-31 | 2003-12-19 | Fremgangsmåde til rensning af alfa-1-antitrypsin |
Country Status (13)
Country | Link |
---|---|
US (8) | US7777006B2 (da) |
EP (4) | EP3543254A1 (da) |
JP (1) | JP5249489B2 (da) |
AU (2) | AU2003301108B2 (da) |
CA (1) | CA2511986C (da) |
DK (3) | DK3006462T3 (da) |
ES (3) | ES2564627T3 (da) |
HK (1) | HK1152007A1 (da) |
HU (2) | HUE027327T2 (da) |
LU (1) | LU93072I2 (da) |
PT (1) | PT1590061E (da) |
SI (2) | SI2295126T1 (da) |
WO (1) | WO2004060528A1 (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7777006B2 (en) | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
AU2004263900A1 (en) | 2003-08-08 | 2005-02-17 | Arriva Pharmaceuticals, Inc. | Methods of protein production in yeast |
PL1664123T5 (pl) * | 2003-09-22 | 2012-04-30 | Kamada Ltd | Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie |
CA2545458A1 (en) * | 2003-11-10 | 2005-05-26 | Arriva-Prometic Inc. | Dry recombinant human alpha 1-antitrypsin formulation |
GB2446550B (en) * | 2005-11-28 | 2010-12-08 | Proteomtech Inc | Methods for production of recombinant alpha1-antitrypsin |
GB0524432D0 (en) * | 2005-11-30 | 2006-01-11 | Nhs Blood & Transplant | Method |
US8772240B2 (en) | 2006-05-19 | 2014-07-08 | Baxter International Inc. | Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases |
NZ595384A (en) * | 2007-08-17 | 2012-03-30 | Csl Behring Gmbh | Methods for purification of alpha-1-antitrypsin and apolipoprotein A-I |
EP2321336A1 (en) * | 2008-07-18 | 2011-05-18 | Talecris Biotherapeutics, Inc. | Method of preparing alpha-1 proteinase inhibitor |
JP2013510158A (ja) * | 2009-11-03 | 2013-03-21 | グリフオルス・セラピユーテイクス・インコーポレーテツド | α‐1プロテイナーゼインヒビターのための組成物、方法およびキット |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
CN103379949B (zh) * | 2010-10-11 | 2016-09-14 | 艾伯维巴哈马有限公司 | 蛋白纯化方法 |
CN102558295A (zh) * | 2010-12-28 | 2012-07-11 | 同路生物制药有限公司 | 生产α1抗胰蛋白酶的方法 |
CN102180966B (zh) * | 2011-01-28 | 2013-04-03 | 哈尔滨派斯菲科生物制药股份有限公司 | 一种规模化生产人α1-抗胰蛋白酶的方法 |
US9353165B2 (en) | 2012-07-25 | 2016-05-31 | Grifols, S.A. | Purification of cell culture derived alpha1 protease inhibitor |
ES2940304T3 (es) * | 2013-06-05 | 2023-05-05 | Csl Ltd | Proceso para preparar apolipoproteína A-I (Apo A-I) |
EP3869196B1 (en) * | 2013-11-07 | 2023-11-15 | Boston Cell Standards Inc. | Quantitative controls and calibrators for cellular analytes |
US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
CN107163138B (zh) * | 2017-03-28 | 2021-02-09 | 深圳市卫光生物制品股份有限公司 | 一种人血浆蛋白α1-抗胰蛋白酶的分离纯化方法 |
IL267923B2 (en) | 2018-08-02 | 2023-06-01 | Grifols Worldwide Operations Ltd | The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it |
JP2023502303A (ja) * | 2019-09-20 | 2023-01-24 | プラズマ テクノロジーズ エルエルシー | 治療用タンパク質組成物及び方法 |
CN112409476B (zh) * | 2020-08-13 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 四种血液来源蛋白的纯化方法 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE629149A (da) | 1962-03-03 | |||
DE1189674B (de) | 1963-06-12 | 1965-03-25 | Behringwerke Ag | Verfahren zur Isolierung von alpha-Antitrypsin |
US3293326A (en) | 1965-07-06 | 1966-12-20 | Sun Oil Co | Dyeable interpolymers consisting of alpha-olefins and a nitrogen containing compound |
US4623717A (en) | 1980-03-05 | 1986-11-18 | Miles Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
US4440679A (en) | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
JPS584728A (ja) * | 1981-05-01 | 1983-01-11 | メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン | α−1−抗トリプシンの精製 |
EP0067293B1 (en) | 1981-05-01 | 1986-06-25 | Medical Research Institute of San Francisco | Method for isolating alpha-1-antitrypsin |
US4439358A (en) | 1982-06-17 | 1984-03-27 | Miles Laboratories, Inc. | Method of preparing alpha-1-proteinase inhibitor |
US4379087A (en) | 1982-06-17 | 1983-04-05 | Cutter Laboratories, Inc. | Method of preparing alpha-1-proteinase inhibitor |
JPS59128335A (ja) | 1983-01-12 | 1984-07-24 | Fujirebio Inc | α↓1−アンチトリプシンの分離取得方法 |
US4820805A (en) | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
US4683294A (en) | 1985-04-03 | 1987-07-28 | Smith Kline Rit, S.A. | Process for the extraction and purification of proteins from culture media producing them |
US4684723A (en) | 1985-09-11 | 1987-08-04 | Miles Laboratories, Inc. | Method of separating proteins from aqueous solutions |
US4697003A (en) | 1985-11-01 | 1987-09-29 | Miles Laboratories, Inc. | Method of preparing alpha-1-proteinase inhibitor |
US4656254A (en) | 1985-12-02 | 1987-04-07 | Miles Laboratories, Inc. | Method of preparing alpha-1-proteinase inhibitor and antithrombin III |
US4629567A (en) * | 1986-03-07 | 1986-12-16 | Smithkline-Rit | Alpha-1-antiprotease purification |
DE3615171A1 (de) | 1986-05-05 | 1987-11-12 | Hans Ing Grad Kern | Einrichtung zum reinigen von rohrleitungen |
US4749783A (en) | 1986-07-11 | 1988-06-07 | Miles Laboratories, Inc. | Viral inactivation and purification of active proteins |
US5114863A (en) | 1986-09-30 | 1992-05-19 | Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College | Immunosorbant assay for α-1-antitrypsin, kit employing said assay, monoclonal antibody to α-1-antitrypsin, and hybridoma for producing said monoclonal antibody |
FR2610633B1 (fr) | 1987-02-05 | 1992-09-18 | Lille Transfusion Sanguine | Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament |
DE3877041T2 (de) * | 1987-04-27 | 1993-04-22 | Miles Inc | Verfahren zur herstellung von hochgereinigtem alpha-1-proteinase-inhibitor. |
US4876241A (en) | 1987-05-22 | 1989-10-24 | Armour Pharmaceutical Company | Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants |
DE68911834T2 (de) | 1988-10-13 | 1994-06-23 | Sandoz Ag | Verfahren zur Herstellung von 7-substituierten Hept-6-en- und Heptansäuren und Derivaten davon. |
US5169936A (en) | 1989-04-14 | 1992-12-08 | Biogen, Inc. | Protein purification on immobilized metal affinity resins effected by elution using a weak ligand |
EP0421309B2 (en) | 1989-10-02 | 2001-08-16 | Novartis Nutrition AG | Protein hydrolysates |
US6187572B1 (en) | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
FR2672895B1 (fr) | 1991-02-15 | 1995-05-12 | Transgene Sa | Procede de purification d'une proteine fortement glycosylee. |
KR100246082B1 (ko) | 1991-07-02 | 2000-04-01 | 인헤일, 인코오포레이티드 | 에어로졸화된약제를전달하는방법및장치 |
EP0629135B1 (en) | 1992-03-02 | 2000-07-26 | Bioeng, Inc. | Viral inactivation method |
IT1271463B (it) * | 1993-12-16 | 1997-05-28 | Sclavo Spa | Processo per l'estrazione e purificazione dell'alfal-antitripsina (alfal-pi)dalla frazione iv-1 di cohn. |
DE4407837C1 (de) | 1994-03-09 | 1995-08-17 | Octapharma Ag | Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie |
US6096216A (en) | 1994-06-09 | 2000-08-01 | American National Red Cross | Iodinated matrices for disinfecting biological fluids |
US6284874B1 (en) | 1994-06-17 | 2001-09-04 | Alpha Therapeutic Corporation | Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste |
US5610285A (en) | 1994-08-24 | 1997-03-11 | Bayer Corporation | Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions |
JPH0899999A (ja) | 1994-09-30 | 1996-04-16 | Chemo Sero Therapeut Res Inst | α1プロテアーゼインヒビターの製造方法 |
US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US5616693A (en) | 1996-07-01 | 1997-04-01 | Alpha Therapeutic Corporation | Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste |
AT407114B (de) | 1997-06-10 | 2000-12-27 | Immuno Ag | Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung |
US6369048B1 (en) | 1998-01-12 | 2002-04-09 | V.I. Technologies, Inc. | Methods and compositions for inactivating viruses |
US6106773A (en) | 1998-09-24 | 2000-08-22 | American National Red Cross | Pathogen inactivating compositions for disinfecting biological fluids |
US6093804A (en) | 1998-09-24 | 2000-07-25 | American National Red Cross | Method for purification of alpha-1 proteinase inhibitor |
US6403646B1 (en) * | 1999-06-30 | 2002-06-11 | David H. Perlmutter | Method for the treatment of alpha-1-antitrypsin deficiency and related pathologies |
US6436344B1 (en) | 1999-11-02 | 2002-08-20 | American National Red Cross | Method of inactivating pathogens |
US6462180B1 (en) | 1999-11-24 | 2002-10-08 | Bayer Corporation | Method of preparing α-1 proteinase inhibitor |
DE10022092A1 (de) * | 2000-05-08 | 2001-11-15 | Aventis Behring Gmbh | Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung |
JP4287147B2 (ja) | 2000-11-02 | 2009-07-01 | イミュノセルラー・セラピューティクス・リミテッド | 小細胞肺癌(sclc)の検出および治療のためのモノクローナル抗体および細胞表面抗原 |
EP1343809B2 (en) | 2000-12-14 | 2023-03-15 | Grifols Therapeutics Inc. | Method of preparing alpha-1 proteinase inhibitor |
US7777006B2 (en) * | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
US10334303B1 (en) | 2014-12-31 | 2019-06-25 | The Directv Group, Inc. | Systems and methods for personalized feature setup and parental guidance sensing |
-
2002
- 2002-12-31 US US10/334,303 patent/US7777006B2/en active Active
-
2003
- 2003-12-19 PT PT38148755T patent/PT1590061E/pt unknown
- 2003-12-19 SI SI200332465A patent/SI2295126T1/sl unknown
- 2003-12-19 EP EP19168046.1A patent/EP3543254A1/en not_active Withdrawn
- 2003-12-19 ES ES10182334.2T patent/ES2564627T3/es not_active Expired - Lifetime
- 2003-12-19 JP JP2004565589A patent/JP5249489B2/ja not_active Expired - Lifetime
- 2003-12-19 EP EP10182334.2A patent/EP2295126B1/en not_active Revoked
- 2003-12-19 WO PCT/US2003/040560 patent/WO2004060528A1/en active Application Filing
- 2003-12-19 AU AU2003301108A patent/AU2003301108B2/en not_active Expired
- 2003-12-19 DK DK15193455.1T patent/DK3006462T3/da active
- 2003-12-19 EP EP03814875.5A patent/EP1590061B1/en not_active Expired - Lifetime
- 2003-12-19 ES ES15193455T patent/ES2733841T3/es not_active Expired - Lifetime
- 2003-12-19 ES ES03814875.5T patent/ES2515816T3/es not_active Expired - Lifetime
- 2003-12-19 DK DK10182334.2T patent/DK2295126T3/da active
- 2003-12-19 EP EP15193455.1A patent/EP3006462B1/en not_active Revoked
- 2003-12-19 CA CA2511986A patent/CA2511986C/en not_active Expired - Lifetime
- 2003-12-19 DK DK03814875.5T patent/DK1590061T3/da active
- 2003-12-19 HU HUE10182334A patent/HUE027327T2/en unknown
- 2003-12-19 SI SI200332391T patent/SI1590061T1/sl unknown
-
2009
- 2009-12-10 AU AU2009248429A patent/AU2009248429B2/en not_active Expired
-
2010
- 2010-08-13 US US12/855,721 patent/US8124736B2/en not_active Expired - Fee Related
-
2011
- 2011-06-15 HK HK11106098.5A patent/HK1152007A1/zh not_active IP Right Cessation
-
2012
- 2012-02-28 US US13/385,642 patent/US8722624B2/en not_active Expired - Lifetime
-
2014
- 2014-03-24 US US14/223,010 patent/US20140323405A1/en not_active Abandoned
-
2015
- 2015-07-17 US US14/802,885 patent/US9320783B2/en not_active Expired - Fee Related
-
2016
- 2016-03-18 US US15/074,266 patent/US9950046B2/en not_active Expired - Lifetime
- 2016-05-12 LU LU93072C patent/LU93072I2/fr unknown
- 2016-05-19 HU HUS1600026C patent/HUS1600026I1/hu unknown
-
2018
- 2018-03-12 US US15/918,614 patent/US10335467B2/en not_active Expired - Fee Related
-
2019
- 2019-05-14 US US16/411,627 patent/US11224643B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3473251T3 (da) | Nikotin-cellulose-kombination | |
DE60328309D1 (de) | Ssigkeiten | |
ATE457980T1 (de) | Aryloxime | |
ATE534648T1 (de) | C-6-modifizierte indazolylpyrrolotriazine | |
DE10393374D2 (de) | Zusammensetzung | |
FR2862654B1 (fr) | Composition amylacee filmogene | |
ATE427876T1 (de) | Luftkissenboot | |
ATE318817T1 (de) | Aza-arylpiperazine | |
SE0500163L (sv) | Sammansättning | |
DK3006462T3 (da) | Alfa-1-antitrypsin-sammensætning | |
DE50212349D1 (de) | Hirurgie | |
DE50212360D1 (de) | Anfahrhilfesteuerungsvorrichtung | |
DK1561472T3 (da) | Faststofsammensætning | |
ATE349458T1 (de) | Etonogestrelester | |
DE60320902D1 (de) | Zusammensetzungen mit ausgelöster Freisetzung | |
ATA1572002A (de) | Managementspleisskassette | |
ATA4142004A (de) | Trägerverbau | |
ATE469773T1 (de) | Zugöse | |
ATA19152002A (de) | Hubkupplung | |
NO20044140D0 (no) | New Composition | |
ATE396192T1 (de) | N-sulfonylaminothiazole | |
DE50300322D1 (de) | Zylinderkopfdichtung | |
DE10244834B8 (de) | Suszeptometer | |
DE50209283D1 (de) | Tropfbewässerungsrohr | |
DE10211707A8 (de) | Segmentstatormaschine |